Trans-Pacific Partnership Reveals Deadly Cost of American Patents 1
Yves Smith has the Naked Capitalism article Trans-Pacific Partnership Reveals Deadly Cost of American Patents.
While US news stories occasionally mention the breathtaking cost of some medications, they almost always skirt the issue of why American drugs are so grotesquely overpriced by world standards. The pharmaceutical industry has managed to sell the story that it’s because they need all that dough to pay for the cost of finding new drugs.
That account is patently false.
First, part of the story the drug industry chooses to omit is that a substantial portion of drug R&D, and the riskiest part (basic research) is heavily funded by the National Institutes of Health and other government agencies. It’s hard to put all the data together, but the latest estimates I’ve seen put the total funded by the government at over 30%.
Second, Big Pharma spends more on marketing [than] on R&D. And it markets in the highest cost manner possible: in person sales calls to small business owners (doctors). The fact that it is worth it to sell in such an exceptionally high cost manner is proof of fat margins (the marginal value of a sale supports such a costly sales effort).
Third, and this is where the foreign debate over the TransPacific Partnership comes in, one of the big reasons US drugs are so costly is we allow drug companies to milk patents to a degree that is unparalleled elsewhere.
And this is only the beginning of the article before she gets really revved up.
When I first heard politicians telling us that we need treaties protecting our “intellectual property” rights, it sounded like a plausible story. The politicians implied that those nasty people in other countries were most uncivilized not to respect our “intellectual property” rights.
It is becoming more and more clear what an abusive concept we have in our American style “intellectual property” protections. When even President Obama repeats this malarkey, just do your own internal translation to “intellectual property” abuse.